Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
基本信息
- 批准号:7691736
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-25 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAminobutyric AcidsAngiotensin IIAutonomic nervous systemBaroreflexBioavailableBiochemicalBlood PressureCardiovascular PhysiologyCellsDataEquilibriumFamilyGene TransferGenerationsGlutamate ReceptorGlutamatesGoalsGrantHypertensionHypothalamic structureKidneyLaboratoriesLaboratory ResearchLeadLeftMAP Kinase GeneMaintenanceMediatingMediationMentorsMetabolic syndromeMetabolismMitogen-Activated Protein KinasesN-Methyl-D-Aspartate ReceptorsNatureNerveNeuronsNeurotransmittersNitric OxideObesityOxidasesParacrine CommunicationPathway interactionsPhasePhysiologicalPopulationReactive Oxygen SpeciesRegulationRoleSignal PathwaySignal TransductionSignaling MoleculeSiteSodiumSpinal CordStimulusSubfornical OrganSuperoxidesTestingThird ventricle structureUp-Regulationbiological adaptation to stressblood pressure regulationcareerenergy balancegamma-Aminobutyric Acidhindbrainneurotransmissionparacrineparaventricular nucleus
项目摘要
My career goal is to have an independent research laboratory exploring the direct neuronal signaling
pathways in the paraventricular nucleus (PVN) that influence hypertension. The PVN is an integrative region
of the hypothalamus involved in the regulation of metabolic processes, stress responses, cardiovascular
function/blood pressure regulation and the autonomic nervous system. The overall hypothesis is that
sodium-dependent hypertension is associated with increased excitatory neurotransmission and
hypertension that is the result of changes within the PVN. In part due to altered paracrine signaling,
specifically nitric oxide (NO) and superoxide (O2-) interactions, influencing neurotransmitters. In addition, an
upregulation of intracellular signaling families, phosphatidylinositol 3-kinase (PI3-kinase) and mitogen
activated protein kinase (MARK), further amplifies excitatory neurotransmission resulting in hypertension.
The goal is to use an integrative approach, using biochemical, gene transfer and physiological studies, to
examine how both paracrine and intracellular signaling changes in the PVN to increase excitatory
sympathoadrenal function and elevate blood pressure. To achieve this goal 4 hypotheses will be addressed
(2 during the mentored period and 2 during the independent portion of the grant): Hypothesis #1: NAD(P)H
oxidase is present in the PVN and its activity is increased by Ang II and glutamate, thus elevating O2-
levels in renal wrap hypertension. Hypothesis #2: In renal wrap hypertension, there is elevated O2- which
combines with NO, reducing bioavailable NO and ultimately increasing sympathoadrenal function and blood
pressure. Hypothesis #3: Ang II via the AT1 receptor and Glutamate via the NMDA receptor utilize common
signaling pathways involving an upregulated PI3-kinase signaling cascade, increasing O2-, in turn, elevating
excitatory neurotransmission in hypertension. Hypothesis #4: Enhanced O2- levels act as signaling
molecules that lead to the activation of the MAPK signaling cascade in the PVN, ultimately elevating
excitatory neurotransmission in hypertension. Identifying the changes in paracrine and intracellular signaling
pathways is significantly important for understanding the impact signaling pathways have on
neurotransmitter activity and hypertension. In addition, due to the integrative nature of the PVN, these data
will also provide a glimpse at the role of signaling in other physiological conditions, such as obesity.
我的职业目标是拥有一个独立的研究实验室,探索直接的神经元信号
室旁核(PVN)中影响高血压的通路。PVN是一个一体化的地区
下丘脑参与调节代谢过程,应激反应,心血管
功能/血压调节和自主神经系统总的假设是,
钠依赖性高血压与兴奋性神经传递增加有关,
高血压是PVN内变化的结果。部分原因是旁分泌信号的改变,
特别是一氧化氮(NO)和超氧化物(O2-)的相互作用,影响神经递质。此外,
细胞内信号传导家族、磷脂酰肌醇3-激酶(PI 3-激酶)和促分裂原的上调
活化蛋白激酶(MARK)进一步放大兴奋性神经传递,导致高血压。
其目标是使用一种综合的方法,利用生物化学,基因转移和生理学研究,
检查旁分泌和细胞内信号如何在PVN中改变以增加兴奋性
交感肾上腺功能和升高血压。为了实现这一目标,将讨论4个假设
(2在辅导期间和2在赠款的独立部分):假设#1:NAD(P)H
氧化酶存在于PVN中,其活性通过Ang II和谷氨酸盐增加,从而升高O2-
肾包膜高血压的水平。假设2:在肾包膜高血压中,O2-升高,
与NO结合,减少生物可利用的NO并最终增加交感肾上腺功能和血液
压力假设#3:Ang II通过AT 1受体和谷氨酸通过NMDA受体利用共同的
信号通路涉及上调的PI 3-激酶信号级联,增加O2-,反过来,
高血压中的兴奋性神经传递假设#4:增强的O2水平作为信号
这些分子导致PVN中MAPK信号级联的激活,最终提高
高血压中的兴奋性神经传递确定旁分泌和细胞内信号传导的变化
信号通路对于理解信号通路对
神经递质活性和高血压。此外,由于PVN的综合性质,这些数据
也将提供一个信号在其他生理条件下的作用一瞥,如肥胖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARRIE A NORTHCOTT其他文献
CARRIE A NORTHCOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARRIE A NORTHCOTT', 18)}}的其他基金
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
- 批准号:
7632355 - 财政年份:2008
- 资助金额:
$ 24.9万 - 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
- 批准号:
7904956 - 财政年份:2008
- 资助金额:
$ 24.9万 - 项目类别:
ROS and NO interaction in the PVN during hypertension?
高血压期间 PVN 中 ROS 和 NO 相互作用?
- 批准号:
7057176 - 财政年份:2006
- 资助金额:
$ 24.9万 - 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
- 批准号:
7245319 - 财政年份:2006
- 资助金额:
$ 24.9万 - 项目类别:
Paraventricular Nucleus Signaling Mechanisms in Hypertension
高血压的室旁核信号传导机制
- 批准号:
7323258 - 财政年份:2006
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant














{{item.name}}会员




